These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 15033592)
1. Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays. Baker VA; Harries HM; Waring JF; Duggan CM; Ni HA; Jolly RA; Yoon LW; De Souza AT; Schmid JE; Brown RH; Ulrich RG; Rockett JC Environ Health Perspect; 2004 Mar; 112(4):428-38. PubMed ID: 15033592 [TBL] [Abstract][Full Text] [Related]
2. Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression. Ulrich RG; Rockett JC; Gibson GG; Pettit SD Environ Health Perspect; 2004 Mar; 112(4):423-7. PubMed ID: 15033591 [TBL] [Abstract][Full Text] [Related]
3. Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate. Kramer JA; Blomme EA; Bunch RT; Davila JC; Jackson CJ; Jones PF; Kolaja KL; Curtiss SW Toxicol Pathol; 2003; 31(4):417-31. PubMed ID: 12851107 [TBL] [Abstract][Full Text] [Related]
4. Gene expression analysis of peroxisome proliferators- and phenytoin-induced hepatotoxicity using cDNA microarray. Jung JW; Park JS; Hwang JW; Kang KS; Lee YS; Song BS; Lee GJ; Yeo CD; Kang JS; Lee WS; Jeon KS; Um CH; Kim YS; Oh MJ; Youn JP; Li P; Park JE; Hwang SY J Vet Med Sci; 2004 Nov; 66(11):1329-33. PubMed ID: 15585944 [TBL] [Abstract][Full Text] [Related]
5. Pooling samples within microarray studies: a comparative analysis of rat liver transcription response to prototypical toxicants. Jolly RA; Goldstein KM; Wei T; Gao H; Chen P; Huang S; Colet JM; Ryan TP; Thomas CE; Estrem ST Physiol Genomics; 2005 Aug; 22(3):346-55. PubMed ID: 15914576 [TBL] [Abstract][Full Text] [Related]
6. Biomarker evaluation of skeletal muscle toxicity following clofibrate administration in rats. Bodié K; Buck WR; Pieh J; Liguori MJ; Popp A Exp Toxicol Pathol; 2016 May; 68(5):289-99. PubMed ID: 27020044 [TBL] [Abstract][Full Text] [Related]
7. Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate. Moffit JS; Koza-Taylor PH; Holland RD; Thibodeau MS; Beger RD; Lawton MP; Manautou JE Toxicol Appl Pharmacol; 2007 Jul; 222(2):169-79. PubMed ID: 17585979 [TBL] [Abstract][Full Text] [Related]
8. Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene. Waring JF; Ulrich RG; Flint N; Morfitt D; Kalkuhl A; Staedtler F; Lawton M; Beekman JM; Suter L Environ Health Perspect; 2004 Mar; 112(4):439-48. PubMed ID: 15033593 [TBL] [Abstract][Full Text] [Related]
9. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver. Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495 [TBL] [Abstract][Full Text] [Related]
10. Cetaben versus clofibrate: comparison of toxicity and peroxisome proliferation in rats. Fort FL; Stein HH; Langenberg K; Lewkowski JP; Heyman IA; Kesterson JW Toxicology; 1983 Nov; 28(4):305-11. PubMed ID: 6606240 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors: finding the orphan a home. Green S; Wahli W Mol Cell Endocrinol; 1994 Apr; 100(1-2):149-53. PubMed ID: 8056148 [TBL] [Abstract][Full Text] [Related]
12. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. Ringseis R; Pösel S; Hirche F; Eder K Pharmacol Res; 2007 Aug; 56(2):175-83. PubMed ID: 17644405 [TBL] [Abstract][Full Text] [Related]
13. Decrease of hepatic stellate cells in rats with enhanced sensitivity to clofibrate-induced hepatocarcinogenesis. Yamana D; Shimizu T; Fan Y; Miura T; Nanashima N; Yamada T; Hakamada K; Tsuchida S Cancer Sci; 2011 Apr; 102(4):735-41. PubMed ID: 21214675 [TBL] [Abstract][Full Text] [Related]
14. Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators; di(2-ethylhexyl) phthalate, aluminium clofibrate and simfibrate. Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y Cancer Lett; 1990 Aug; 53(1):33-8. PubMed ID: 2397479 [TBL] [Abstract][Full Text] [Related]
15. Acute hepatotoxicity: a predictive model based on focused illumina microarrays. Zidek N; Hellmann J; Kramer PJ; Hewitt PG Toxicol Sci; 2007 Sep; 99(1):289-302. PubMed ID: 17522070 [TBL] [Abstract][Full Text] [Related]
17. Regulation of fatty acid transport protein and mitochondrial and peroxisomal beta-oxidation gene expression by fatty acids in developing rats. Ouali F; Djouadi F; Merlet-Bénichou C; Riveau B; Bastin J Pediatr Res; 2000 Nov; 48(5):691-6. PubMed ID: 11044493 [TBL] [Abstract][Full Text] [Related]
18. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats. Muroya Y; Ito O Clin Exp Nephrol; 2016 Dec; 20(6):862-870. PubMed ID: 26949064 [TBL] [Abstract][Full Text] [Related]
19. Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Gerhold D; Lu M; Xu J; Austin C; Caskey CT; Rushmore T Physiol Genomics; 2001 Apr; 5(4):161-70. PubMed ID: 11328961 [TBL] [Abstract][Full Text] [Related]
20. Clofibrate treatment in pigs: effects on parameters critical with respect to peroxisome proliferator-induced hepatocarcinogenesis in rodents. Luci S; Giemsa B; Hause G; Kluge H; Eder K BMC Pharmacol; 2007 Apr; 7():6. PubMed ID: 17437637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]